Jean paul clozel biography of martin

Martine Clozel (born 27 December 1955) is a scientist, entrepreneur and co-founder of Actelion and Idorsia.

Education and career

Clozel studied at the University of Nancy and the University of California in San Francisco. She also attended further training in physiology and pharmacology at McGill University.

In 1997, she founded Actelion with her husband Jean-Paul Clozel. The company was sold in 2017 to the American pharmaceutical and consumer products company Johnson & Johnson for US$30 billion. Martine Clozel founded the pharmaceutical company Idorsia in 2017 and has since served as head of research. She is one of the most successful female company founders in Switzerland.

Awards

References

External links

Jean-Paul: The beginning and the end. In the beginning, we had the dream to create a real company with affiliates in Japan, the US and Europe with research. I thought it was never possible. It’s like creating a car company: Tesla made it, but this is the exception. It was impossible to think you could compete against Ford, against Renault. We were competing against Roche, Novartis, Merck, GSK. I think that’s really something I was proud of, because we succeeded. At the end, we were bought by Johnson & Johnson, but we could create Idorsia. No one lost their job, no project was stopped. Johnson & Johnson got the drugs they wanted, which

is good for the patient. In such an acquisition, this is the only time that’s happened. It’s unique in the pharma industry, that the commercial part and the drugs went to Johnson & Johnson but they let us continue our research projects.

• Martine Clozel was selected for the Prix Suisse award for her contribution to research, science, and medicine and was presented with the Prix Suisse by the National Council President Irène Kälin
• The Prix Suisse is an annual award presented by the non-profit organization Initiative Switzerland to individuals who have made outstanding contributions to Switzerland

Allschwil, Switzerland – November13, 2022
Idorsia Ltd (SIX: IDIA) today announced that Chief Scientific Officer Martine Clozel was honored by the organization Initiative Switzerland with the annual Prix Suisse Award at an award ceremony in the Kursaal Bern on Saturday, 12 November. The Prix Suisse is a national award and represents the highest distinction for outstanding achievements in Switzerland and was presented to Martine by Irène Kälin, The President of the National Council of Switzerland.

In her introduction, Irène Kälin commented:
“Martine Clozel would have deserved an award for every single facet of her diverse work. The sum of all her work is greater than what she has achieved as a doctor, entrepreneur, and researcher in the respective fields. An incredibly impressive woman."

Martine Clozel is a Founder and Chief Scientific Officer at Idorsia. Previously, she had co-founded Actelion alongside Jean-Paul Clozel, Walter Fischli, and Thomas Widmann. Martine has published more than 150 peer-reviewed articles, authored more than 40 patent applications, and co-authored several books in the areas of endothelin and orexin research and their applications. The research from Martine and the teams at Actelion, and then Idorsia, has resulted in several new treatments for patients. After years of research, innovative life changing drugs are now available, in the fields of pulmonary arterial hypertension, multiple sclerosis, the prevention of the cerebral consequences of aneurysmal rupture, and chronic insomnia. In 2008, Martine was awarded "Chevalier dans l'Ordre de la Légion d'Honneur